Australia's Uscom jumps on regulatory nod for BP monitor sale in China

USCOM

19/04/2021 04:29

** Shares of Uscom Ltd  UCM.AX  climb as much as 16.1% to
A$0.180, their highest since March 29
    ** The medical device maker says its BP+ non-invasive
central blood pressure monitor has received Chinese National
Medical Products Administration (NMPA) approval for sale into
China  urn:newsml:reuters.com:*:nASN00130K
    ** Says NMPA certificate will be issued within the next 10
working days
    ** Stock posts its biggest intra-day percentage gain since
Dec. 9, 2020
    ** More than 1 mln shares change hands, compared with 30-day
average vol of 157,413 shares
    ** Stock down 3.1% this year as of last close
    


 (Reporting by Riya Sharma in Bengaluru)
 ((Riya.Sharma@thomsonreuters.com;))